Fmr LLC Vertex Pharmaceuticals Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fmr LLC holds 10,729,428 shares of VRTX stock, worth $5.02 Billion. This represents 0.33% of its overall portfolio holdings.

Number of Shares

10,729,428

Previous 10,673,520 0.52%

Holding current value

$5.02 Billion

Previous $4.46 Billion 12.72%

% of portfolio

0.33%

Previous 0.31%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $22 Million - $27.1 Million	55,908 Added 0.52%	10,729,428 $5.03 Billion
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $940 Million - $1.03 Billion	-2,305,991 Reduced 17.77%	10,673,520 $4.46 Billion
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $474 Million - $567 Million	-1,380,926 Reduced 9.62%	12,979,511 $5.28 Billion
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $90.7 Million - $97.2 Million	-268,229 Reduced 1.83%	14,360,437 $4.99 Billion
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $518 Million - $580 Million	-1,647,189 Reduced 10.12%	14,628,666 $5.15 Billion
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $450 Million - $514 Million	-1,590,436 Reduced 8.9%	16,275,855 $5.13 Billion
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $143 Million - $161 Million	500,268 Added 2.88%	17,866,291 $5.16 Billion
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $168 Million - $187 Million	613,012 Added 3.66%	17,366,023 $5.03 Billion
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $839 Million - $1.04 Billion	3,571,298 Added 27.09%	16,753,011 $4.72 Billion
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $905 Million - $1.07 Billion	4,087,860 Added 44.95%	13,181,713 $3.44 Billion
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $746 Million - $942 Million	4,216,754 Added 86.46%	9,093,853 $2 Billion
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $174 Million - $194 Million	-956,964 Reduced 16.4%	4,877,099 $885 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $1.09 Billion - $1.29 Billion	5,834,063 New	5,834,063 $1.18 Billion

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account